Screen · Berkshire Criteria

Buffett Quality Screen

Buffett's "wonderful business" criteria, quantified into six dimensions: earnings record (20), ROE quality (25 — Fortune's double standard), low leverage (15), pricing power (15), business stability (15) and capital efficiency (10), for a 0–100 total. The entry gate is the first of Berkshire's acquisition criteria — at least $50M average pre-tax earnings over the last three fiscal years (banks and insurers excluded, as leverage is their business model; investment trusts and closed-end funds excluded, as they are portfolios rather than operating companies). Recomputed periodically from each company's last ten fiscal years; cross-listings merged by canonical ticker. Hover the score for the six-dimension breakdown; companies we cover link to their report. Gefiltert nach market "US", market cap "Mega ≥$200B", profit streak "Full 10 yr": 37 match(Filter löschen).

# Titel Mkt Cap Score Baillie 10Y ROE Profit Streak Net Debt/Eq Gross Margin Analyse FY
1 Visa Inc. Class A V · USA $684B
95/100 Exzellent
49/100 35.7%low 18.2% 10 yr+ 0.1× 81% Visa Inc. Long-Term Business Owner Research25. Mai 2026 · Watch FY2025
2 KLA Corporation KLAC · USA $239B
93/100 Exzellent
52/100 55.9%low 44.2% 10 yr+ 0.2× 61% KLA Corporation: A Deep Value Investment Analysis22. Mai 2026 · Watch FY2026
3 ASML Holding NV ADR ASML · USA $626B
92/100 Exzellent
55/100 36.5%low 15.9% 10 yr+ Net cash 49% ASML Holding N.V.: A €43–45bn Guidance Reset, 38x Forward Earnings, and No Conservative Margin of Safety11. August 2026 · Hold FY2025
4 Applied Materials Inc AMAT · USA $403B
92/100 Exzellent
48/100 38.9%low 23.8% 10 yr+ Net cash 46% Applied Materials Deep Value Investment Research21. Mai 2026 · Watch FY2025
5 Microsoft Corporation MSFT · USA $3.5T
91/100 Exzellent
67/100 34.6%low 20.0% 10 yr+ 0.1× 68% Microsoft: Azure Demand Is Real and the Moat Is Intact, but 393 USD Already Prices a Clean Conversion of the 190 Billion USD Capex Wave29. Juli 2026 · Hold FY2026
6 Lam Research Corp LRCX · USA $367B
90/100 Exzellent
49/100 48.3%low 24.3% 10 yr+ Net cash 47% Lam Research from a Long-Term Business Owner's Perspective22. Mai 2026 · Watch FY2026
7 American Express Company AXP · USA $227B
89/100 Exzellent
46/100 27.8%low 13.6% 10 yr+ 0.3× 87% American Express Closed-Loop Payments Platform Research23. Mai 2026 · Watch FY2025
8 Arista Networks ANET · USA $227B
88/100 Exzellent
56/100 24.1%low 15.3% 10 yr+ Net cash 64% Arista Networks: Eine Langfriststudie zum Marktführer im Data-Center-Switching23. Mai 2026 · Beobachten FY2025
9 Cisco Systems Inc CSCO · USA $457B
87/100 Exzellent
45/100 22.4%low 0.3% 10 yr+ 0.3× 63% Cisco Systems: A Value-Investing Deep Dive22. Mai 2026 · Watch FY2025
10 Costco Wholesale Corp COST · USA $422B
87/100 Exzellent
45/100 25.4%low 19.5% 10 yr+ Net cash 13% Costco: A Deep-Dive Value Investing Analysis21. Mai 2026 · Watch FY2025
11 Mastercard Inc MA · USA $502B
86/100 Exzellent
49/100 60.0%low 60.0% 10 yr+ 1.0× 77% Mastercard Deep Value Investment Research25. Mai 2026 · Watch FY2025
12 Alphabet Inc Class C GOOG · USA $4.4T
85/100 Exzellent
65/100 21.7%low 8.3% 10 yr+ Net cash 57% Alphabet: Search and Cloud Are Both Accelerating, but a 200 Billion Dollar Build Has Turned Free Cash Flow Negative and 333.68 Dollars Already Prices In the Base Case31. Juli 2026 · Hold FY2025
13 Meta Platforms Inc. META · USA $1.4T
84/100 Exzellent
56/100 24.3%low 17.3% 10 yr+ 0.0× 82% Meta Platforms: Revenue Grew 28% While Free Cash Flow Fell to 784 Million Dollars, and 556.71 Dollars Buys the Base Case With No Margin of Safety1. August 2026 · Hold FY2025
14 UnitedHealth Group Incorporated UNH · USA $376B
84/100 Exzellent
43/100 21.4%low 12.8% 10 yr+ 0.5× 23% UnitedHealth Group (UNH): A Deep-Dive Value Investing Study25. Mai 2026 · Watch FY2025
15 Procter & Gamble Company PG · USA $335B
84/100 Exzellent
44/100 26.6%low 8.3% 10 yr+ 0.4× 50% P&G Deep-Dive Value Research Report25. Mai 2026 · Watch FY2026
16 Apple Inc. AAPL · USA $4.5T
83/100 Exzellent
43/100 54.7%low 35.6% 10 yr+ 0.8× 41% Apple Inc.: Strip Out the Tariff Refunds and the 50.1% Margin Becomes 48.1%, While 308.91 Dollars Earns Less Than the Ten-Year Treasury1. August 2026 · Hold FY2025
17 Taiwan Semiconductor Manufacturing TSM · USA $2.1T
82/100 Exzellent
57/100 26.3%low 21.8% 10 yr+ Net cash 53% TSMC: Earnings Have Outrun the Share Price to a 28.1x Trailing Multiple, but a Limit-Up Close at NT$2,425 Leaves Only a Limited Margin of Safety31. Juli 2026 · Hold FY2025
18 Johnson & Johnson JNJ · USA $618B
82/100 Exzellent
48/100 25.5%low 2.2% 10 yr+ 0.3× 69% Johnson & Johnson Deep Value Analysis: A Good Company Is Not Cheap25. Mai 2026 · Watch FY2025
19 Texas Instruments Incorporated TXN · USA $252B
82/100 Exzellent
49/100 46.2%low 28.4% 10 yr+ 0.6× 63% Texas Instruments Analog and Embedded Processors Research23. Mai 2026 · Watch FY2025
20 NVIDIA Corporation NVDA · USA $4.9T
81/100 Exzellent
66/100 39.9%low 19.8% 10 yr+ Net cash 64% NVIDIA: Demand Has Broadened Beyond the Hyperscalers, but Its Funding Base Has Not, and 197 USD Already Prices Continued Excellence29. Juli 2026 · Hold FY2026
21 The Coca-Cola Company KO · USA $377B
79/100 Stark
47/100 36.8%low 7.3% 10 yr+ 1.0× 61% Coca-Cola Deep Value Investment Research25. Mai 2026 · Watch FY2025
22 The Home Depot Inc HD · USA $337B
78/100 Stark
45/100 60.0%low 60.0% 10 yr+ 5.0× 34% The Home Depot: A Value Investing Deep Dive25. Mai 2026 · Watch FY2026
23 SAP SE ADR SAP · USA $231B
77/100 Stark
45/100 12.6%low 5.7% 10 yr+ Net cash 71% SAP: A High-Quality Incumbent Late in Its Cloud Migration, Now Priced for Proof Rather Than Possibility26. Juni 2026 · Hold FY2025
24 Philip Morris International Inc PM · USA $297B
76/100 Stark
46/100 49.2%low 24.0% 10 yr+ 60% Philip Morris International: In-Depth Value Investment Research25. Mai 2026 · Watch FY2025
25 Netflix Inc NFLX · USA $299B
74/100 Stark
51/100 25.2%low 7.0% 10 yr+ 0.2× 40% Netflix: A Long-Term Business Owner's Perspective22. Mai 2026 · Watch FY2025
26 AbbVie Inc ABBV · USA $443B
73/100 Stark
45/100 54.6%low 35.2% 10 yr+ 71% AbbVie: In-Depth Research from a Long-Term Business Owner's Perspective21. Mai 2026 · Watch FY2025
27 Merck & Company Inc MRK · USA $307B
71/100 Stark
46/100 24.4%low 1.0% 10 yr+ 0.7× 70% Merck & Co.: KEYTRUDA and QLEX Generated 50.4% of Second-Quarter Revenue While Subcutaneous Sales Rose to 463 Million Dollars Before the 2028 Patent Cliff5. August 2026 · Hold FY2025
28 International Business Machines IBM · USA $211B
71/100 Stark
46/100 34.1%low 7.5% 10 yr+ 1.6× 52% IBM Long-Term Owner's Perspective Research25. Mai 2026 · Watch FY2025
29 Walmart Inc. WMT · USA $885B
69/100 Stark
46/100 16.0%low 8.4% 10 yr+ 0.6× 25% Walmart Research from a Long-Term Owner's Perspective23. Mai 2026 · Watch FY2026
30 Thermo Fisher Scientific Inc TMO · USA $213B
69/100 Stark
47/100 13.3%low 8.8% 10 yr+ 0.5× 44% Thermo Fisher: A Long-Term Owner's Perspective25. Mai 2026 · Watch FY2025
31 Morgan Stanley MS · USA $331B
68/100 Stark
46/100 11.1%low 7.9% 10 yr+ Net cash 77% Morgan Stanley Deep Value Investment Research Report25. Mai 2026 · Watch FY2025
32 Amgen Inc AMGN · USA $208B
67/100 Stark
43/100 51.4%low 7.8% 10 yr+ 5.3× 76% Amgen Inc. Deep-Dive Value Investing Analysis21. Mai 2026 · Watch FY2025
33 Oracle Corporation ORCL · USA $374B
65/100 Stark
52/100 46.3%low 7.8% 10 yr+ 2.9× 76% Oracle Corporation28. Juli 2026 · Hold FY2026
34 AstraZeneca PLC AZN · USA $279B
64/100 Mittel
51/100 15.4%low 0.3% 10 yr+ 0.5× 78% AstraZeneca: Eine eingehende Analyse15. Juni 2026 · Halten FY2025
35 Siemens AG ADR SIEGY · USA $249B
63/100 Mittel
48/100 13.4%low 7.6% 10 yr+ 0.6× 35% Siemens AG (SIE.XETRA) Zen Horizon Research Report9. Juni 2026 · Watch FY2025
36 Goldman Sachs Group Inc GS · USA $309B
55/100 Mittel
45/100 10.7%low 5.2% 10 yr+ Net cash 65% Goldman Sachs Group Deep Value Investing Analysis25. Mai 2026 · Watch FY2025
37 Linde plc Ordinary Shares LIN · USA $221B
48/100 Eher schwach
47/100 13.9%low 4.7% 10 yr+ 0.6× 32% In-Depth Value Investment Analysis of Linde plc22. Mai 2026 · Watch FY2025

Data and methodology: the six dimensions quantify Berkshire's published acquisition criteria and Buffett's shareholder letters (1981/1987/1991/2007 among others). Qualitative tests in the originals (e.g. "simple, understandable business", "management in place") are out of scope, and price ("available at a fair price") is covered by each report's valuation range instead. Financials come from company annual reports (via EODHD); ratios are computed in reporting currency, the USD gate via static FX. "‡" marks companies whose equity is persistently negative or tiny (ROE falls back to ROCE); "†" marks missing gross profit (operating margin used). Investment trusts and closed-end funds are excluded on two tests — name and financial shape (operating margins beyond what an operating company can achieve); REITs and operating asset managers are unaffected. This is a quantitative first pass, not investment advice. When citing this data, please credit Zen Horizon (zh.app). See our methodology for the scoring process.